Announcements Trials
Browse Landscape

Status

No longer available 20Approved for marketing 17Available 11Temporarily not available 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Expanded_access 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 2

Interventions

telisotuzumab vedotin 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Temporarily not available × Expanded_access × Thoracic × Clear all
NCT04830202 2026-05-13

Expanded Access to Telisotuzumab Vedotin

AbbVie

Temporarily not available
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01297101 2011-02-16

Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy

Shanghai Chest Hospital

Temporarily not available
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡